Thomas R. Alessi

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

Robert R. Henry, Julio Rosenstock, Douglas Logan et al. · Journal of Diabetes and its Complications · 2014 · 79 citations · Full text

Synthetic studies directed toward naturally occurring cyclooctanoids. 2. A stereocontrolled assembly of (.+-.)-pleuromutilin via a remarkable sterically demanding oxy-Cope rearrangement

Robert K. Boeckman, Dane M. Springer, Thomas R. Alessi · Journal of the American Chemical Society · 1989 · 59 citations

Engineering, Biochemistry, Donut Icon +12

Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes

Robert R. Henry, Julio Rosenstock, Douglas Logan et al. · Diabetes Care · 2013 · 43 citations · Full text

DUROS® Technology Delivers Peptides and Proteins at Consistent Rate Continuously for 3 to 12 Months

Catherine M. Rohloff, Thomas R. Alessi, Bing Yang et al. · Journal of Diabetes Science and Technology · 2008 · 42 citations · Full text

Stereocontrol in the intramolecular Diels-Alder reaction. 3. A potentially general method for the synthesis of cis-hydrindenes by use of (Z)-diene units

Robert K. Boeckman, Thomas R. Alessi · Journal of the American Chemical Society · 1982 · 38 citations

Intramolecular Diels-alder Reaction, Derivative (Chemistry), Engineering +12